As of Sep 16
| +2.44 / +2.99%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 105.00, with a high estimate of 105.00 and a low estimate of 105.00. The median estimate represents a +24.96% increase from the last price of 84.03.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.